Recent Advances in Standardization and Quality Control of Polyherbal Formulations for management of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycaemia and is associated with complications affecting multiple organ systems. Interest in medicinal plants and polyherbal formulations has increased because plant-derived phytochemicals may influence glucose metabolism through complementary biological pathways. Polyherbal formulations combine two or more medicinal plants or extracts in defined proportions; however, differences in plant identity, geographical origin, cultivation, harvesting, processing, extraction and storage can alter their composition and quality. This review summarizes approaches used to standardize and control the quality of polyherbal formulations investigated for diabetes management. The review covers authentication of raw herbal materials by botanical, macroscopic, microscopic and molecular methods; physicochemical evaluation; phytochemical screening; marker-based standardization; and testing for contaminants such as heavy metals, pesticide residues, microbes and residual solvents. It also discusses conventional analytical methods and advanced tools, including thin-layer chromatography, high-performance thin-layer chromatography, high-performance liquid chromatography, gas chromatography, chromatographic fingerprinting and metabolomics. Chemometric approaches such as principal component analysis and hierarchical cluster analysis can help compare chemical profiles, identify outliers and assess batch-to-batch consistency. Biological evaluation, including enzyme-inhibition assays, cellular models and appropriate in-vivo studies, may provide complementary evidence of activity and safety. Linking chemical fingerprints with biological findings can strengthen the rationale for selecting quality markers. Overall, no single test test is is s sufficient to charact characterize a complex polyherbal product. A combined, validated quality-control strategy is needed to support identity, purity, consistency and reproducibility. Although some formulations have shown promising glycaemic outcomes in studies, laboratory or preclinical findings alone do not establish clinical efficacy. Well-designed clinical trials, transparent manufacturing controls and compliance with relevant pharmacopoeial and regulatory standards remain important for determining safety, effectiveness and dependable use in diabetes management.
Authors
- Datta More
- Sanjay Bais
- Yuvraj Arjun
Institutions
- Solapur University (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-12
- DOI
- https://doi.org/10.5281/zenodo.24155659
- Primary Topic
- Traditional Chinese Medicine Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00